Nalpropion Pharmaceuticals, Inc. Employee Directory
Pharmaceutical ManufacturingCalifornia, United States51-200 Employees
Nalpropion Pharmaceuticals, Inc. is a patient-focused biopharmaceutical company focused on the treatment of weight loss. Nalpropion was formed on April 17, 2018 as a joint venture among Currax Holdings LLC, Highbridge Capital Management, LLC and Whitebox Advisors LLC. Nalpropion was established for the purposes of purchasing substantially all commercial assets of Orexigen. Our team is creative, passionate, collaborative and determined to succeed. Nalpropion offers prospective employees exciting challenges, unique opportunities for career growth, and a fast-paced environment that emphasizes innovation and achievement.